Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kersting

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2025
Tumor Dose-Response Relationship of [<sup>131</sup>I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [<sup>124</sup>I]MIBG PETAlexandros Moraitis, Andre Prochnow, Thorsten Dirk Poeppel, et al.
EJNMMI Research|February 28, 2021
Evaluation of [<sup>68</sup>Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph visionManuel Weber, Walter Jentzen, Regina Hofferber, et al.
Seminars in Nuclear Medicine|April 10, 2023
Is There a Role of Artificial Intelligence in Preclinical Imaging?Alina Küper, Paul Blanc-Durand, Andrei Gafita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 1, 2023
Evaluation of thresholding methods for the quantification of [<sup>68</sup>Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapyMoon Kim, Robert Seifert, Jana Fragemann, et al.
BMC Cancer|January 15, 2021
Evaluation of <sup>18</sup>F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph visionManuel Weber, Walter Jentzen, Regina Hofferber, et al.
Seminars in Nuclear Medicine|July 16, 2024
Future Perspectives of Artificial Intelligence in Bone Marrow Dosimetry and Individualized Radioligand TherapyAlexandros Moraitis, Alina Küper, Johannes Tran-Gia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Regression of Myocardial <sup>99m</sup>Tc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin AmyloidosisMaria Papathanasiou, Lukas Kessler, Frank M Bengel, et al.
EJNMMI Physics|January 3, 2024
Biodistribution and radiation dosimetry of <sup>124</sup>I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric modelsAlexandros Moraitis, Walter Jentzen, Gloria Reiter, et al.
Scientific Reports|September 2, 2021
Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124David Kersting, Walter Jentzen, Pedro Fragoso Costa, et al.
EJNMMI Physics|February 15, 2021
Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancerDavid Kersting, Walter Jentzen, Miriam Sraieb, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2025
Tumor Dose-Response Relationship of [<sup>131</sup>I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [<sup>124</sup>I]MIBG PETAlexandros Moraitis, Andre Prochnow, Thorsten Dirk Poeppel, et al.
EJNMMI Research|February 28, 2021
Evaluation of [<sup>68</sup>Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph visionManuel Weber, Walter Jentzen, Regina Hofferber, et al.
Seminars in Nuclear Medicine|April 10, 2023
Is There a Role of Artificial Intelligence in Preclinical Imaging?Alina Küper, Paul Blanc-Durand, Andrei Gafita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 1, 2023
Evaluation of thresholding methods for the quantification of [<sup>68</sup>Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapyMoon Kim, Robert Seifert, Jana Fragemann, et al.
BMC Cancer|January 15, 2021
Evaluation of <sup>18</sup>F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph visionManuel Weber, Walter Jentzen, Regina Hofferber, et al.
Seminars in Nuclear Medicine|July 16, 2024
Future Perspectives of Artificial Intelligence in Bone Marrow Dosimetry and Individualized Radioligand TherapyAlexandros Moraitis, Alina Küper, Johannes Tran-Gia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Regression of Myocardial <sup>99m</sup>Tc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin AmyloidosisMaria Papathanasiou, Lukas Kessler, Frank M Bengel, et al.
EJNMMI Physics|January 3, 2024
Biodistribution and radiation dosimetry of <sup>124</sup>I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric modelsAlexandros Moraitis, Walter Jentzen, Gloria Reiter, et al.
Scientific Reports|September 2, 2021
Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124David Kersting, Walter Jentzen, Pedro Fragoso Costa, et al.
EJNMMI Physics|February 15, 2021
Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancerDavid Kersting, Walter Jentzen, Miriam Sraieb, et al.
Pageof 9